GSA Capital Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,240
| Closed | -$785K | – | 1771 |
|
|
2023
Q1 | $785K | Buy |
+3,240
| New | +$785K | 0.08% | 451 |
|
|
2022
Q1 | – | Sell |
-4,780
| Closed | -$405K | – | 1652 |
|
|
2021
Q4 | $405K | Sell |
4,780
-4,376
| -48% | -$371K | 0.05% | 737 |
|
|
2021
Q3 | $731K | Buy |
9,156
+4,153
| +83% | +$332K | 0.07% | 468 |
|
|
2021
Q2 | $487K | Buy |
+5,003
| New | +$487K | 0.05% | 645 |
|
|
2021
Q1 | – | Sell |
-3,334
| Closed | -$371K | – | 1324 |
|
|
2020
Q4 | $371K | Buy |
+3,334
| New | +$371K | 0.06% | 628 |
|
|
2020
Q1 | – | Sell |
-12,241
| Closed | -$1.12M | – | 1349 |
|
|
2019
Q4 | $1.12M | Buy |
12,241
+8,564
| +233% | +$780K | 0.13% | 161 |
|
|
2019
Q3 | $317K | Buy |
+3,677
| New | +$317K | 0.04% | 854 |
|
|
2018
Q3 | – | Sell |
-1,702
| Closed | -$476K | – | 1783 |
|
|
2018
Q2 | $476K | Buy |
+1,702
| New | +$476K | 0.02% | 1183 |
|
|
2015
Q2 | – | Sell |
-894
| Closed | -$61K | – | 2090 |
|
|
2015
Q1 | $61K | Buy |
+894
| New | +$61K | ﹤0.01% | 2047 |
|